Harvest Minerals Ltd

Harvest Minerals Ltd exhibits a fragile capital structure characterized by high leverage and negative equity returns. The company reports total assets of 5,151,190 AUD against total liabilities of 4,887,090 AUD, resulting in total equity of only 264,090 AUD. Long-term debt stands at 3,397,090 AUD, yielding a debt-to-equity ratio of 12.86, which indicates significant financial leverage. Liquidity is constrained, with a current ratio of 0.71, suggesting potential short-term solvency pressures. The market capitalization is 114,722,581.48 AUD, implying a price-to-book ratio of 434.39, which reflects the market's valuation relative to the minimal book equity.

Profitability metrics are deeply negative, reflecting the company's early-stage or distressed operational status. Net income is -5,795,300 AUD, leading to a return on equity of -21.94% and a return on assets of -1.13%. Operating income is -5,791,520 AUD, indicating that core operations are not covering fixed costs. The company generated revenue of 1,750,600 AUD, but gross profit was only 369,780 AUD, resulting in a gross margin of approximately 21.1%. Free cash flow is negative at -5,243,530 AUD, driven by operating cash flow of -526,590 AUD and capital expenditures of -98,510 AUD.

Revenue concentration and segment details are not explicitly broken down in the provided data, but the total revenue figure of 1,750,600 AUD serves as the primary top-line indicator. The company's activity is classified broadly under Chemicals, suggesting its revenue is derived from chemical products or services. Without specific segment data, the revenue mix is assumed to be concentrated in its primary disclosed activity.

Growth trajectory analysis is limited by the absence of historical period data in the input. However, the current revenue of 1,750,600 AUD can be compared to the last actual revenue estimate of 1,628,000 AUD from analyst estimates, suggesting a modest recent increase or variance in reporting periods. The negative net income and cash flow indicate that the company is not yet achieving sustainable organic growth in profitability.

Risk factors include medium liquidity risk and low dilution risk. The key flag notes that net cash is negative after subtracting total debt, highlighting a reliance on external financing or asset liquidation to meet obligations. The high debt-to-equity ratio of 12.86 amplifies financial risk, while the current ratio of 0.71 suggests potential difficulty in meeting short-term liabilities without additional capital.

Recent observations include an analyst estimate of last actual EPS at -0.02 AUD and last actual revenue at 1,628,000 AUD. These figures align closely with the financial snapshot, confirming the company's ongoing losses and modest revenue scale. No specific filing, news, or transcript events are detailed in the input, limiting the scope of recent event analysis.

The company generated positive gross profit in FY-3, indicating underlying operational viability despite recent net losses.

Dilution risk is assessed as low, suggesting limited immediate threat to shareholder equity from share issuance.

Revenue demonstrated a 11.6% CAGR over four years, showing historical growth potential before recent declines.

The debt-to-equity ratio of 12.86 places the company in the bottom quartile of its cohort.

High credit risk flags indicate significant concerns regarding the company's ability to meet its financial obligations.

Operating margins of -3.31% rank in the bottom quartile compared to the chemical industry median.

Revenue A$1.8M, −33,9% YoY; Operating income −58,0% YoY.

• ▍Revenue A$1.8M, −33,9% YoY
• ▍Operating income −58,0% YoY
• ▍Net income −58,0% YoY
• ▍Free cash flow −79,2% YoY
• ▍Net margin -331.0%

Revenue A$3.1M, −63,7% YoY; Operating income −758,0% YoY.

• ▍Revenue A$3.1M, −63,7% YoY
• ▍Operating income −758,0% YoY
• ▍Net income −1 708,0% YoY
• ▍Free cash flow −99,7% YoY
• ▍Net margin -101.5%